Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas M Voll

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Frontiers in Pharmacology|December 21, 2018
FKBP Ligands-Where We Are and Where to Go?Jürgen M Kolos, Andreas M Voll, Michael Bauder, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2024
Antascomicin B stabilizes FKBP51-Akt1 complexes as a molecular glueSabine C Schäfer, Andreas M Voll, Andreas Bracher, et al.
Journal of Medicinal Chemistry|March 5, 2021
Structure-Based Design of High-Affinity Macrocyclic FKBP51 InhibitorsMichael Bauder, Christian Meyners, Patrick L Purder, et al.
Addiction Biology|June 8, 2019
The selective FKBP51 inhibitor SAFit2 reduces alcohol consumption and reinstatement of conditioned alcohol effects in miceLoretta König, Liubov S Kalinichenko, Sabine E Huber, et al.
Angewandte Chemie (International Ed. in English)|April 12, 2021
Macrocyclic FKBP51 Ligands Define a Transient Binding Mode with Enhanced SelectivityAndreas M Voll, Christian Meyners, Martha C Taubert, et al.
Chemical Science|November 25, 2021
Picomolar FKBP inhibitors enabled by a single water-displacing methyl group in bicyclic [4.3.1] aza-amidesJürgen M Kolos, Sebastian Pomplun, Sascha Jung, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Frontiers in Pharmacology|December 21, 2018
FKBP Ligands-Where We Are and Where to Go?Jürgen M Kolos, Andreas M Voll, Michael Bauder, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2024
Antascomicin B stabilizes FKBP51-Akt1 complexes as a molecular glueSabine C Schäfer, Andreas M Voll, Andreas Bracher, et al.
Journal of Medicinal Chemistry|March 5, 2021
Structure-Based Design of High-Affinity Macrocyclic FKBP51 InhibitorsMichael Bauder, Christian Meyners, Patrick L Purder, et al.
Addiction Biology|June 8, 2019
The selective FKBP51 inhibitor SAFit2 reduces alcohol consumption and reinstatement of conditioned alcohol effects in miceLoretta König, Liubov S Kalinichenko, Sabine E Huber, et al.
Angewandte Chemie (International Ed. in English)|April 12, 2021
Macrocyclic FKBP51 Ligands Define a Transient Binding Mode with Enhanced SelectivityAndreas M Voll, Christian Meyners, Martha C Taubert, et al.
Chemical Science|November 25, 2021
Picomolar FKBP inhibitors enabled by a single water-displacing methyl group in bicyclic [4.3.1] aza-amidesJürgen M Kolos, Sebastian Pomplun, Sascha Jung, et al.
Pageof 1